| Nov 22 |
Calculating The Fair Value Of BioSyent Inc. (CVE:RX)
|
| Nov 20 |
BioSyent Releases Financial Results for Q3 and YTD 2024
|
| Nov 20 |
BioSyent Declares Fourth Quarter 2024 Dividend
|
| Nov 13 |
BioSyent Schedules Q3 and YTD 2024 Earnings Release for November 20, 2024
|
| Oct 23 |
BioSyent Inc.'s (CVE:RX) Stock Is Going Strong: Is the Market Following Fundamentals?
|
| Sep 26 |
Should You Be Adding BioSyent (CVE:RX) To Your Watchlist Today?
|
| Sep 20 |
BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
|
| Aug 30 |
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.045
|
| Aug 28 |
BioSyent Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
|
| Aug 26 |
BioSyent Releases Financial Results for Q2 and H1 2024
|
